A patient in New York has been infected with a strain of E. coli highly resistant to last-resort antibiotic treatments, according to an article on the Becker's Infection Control and Clinical Quality website.
This is the second U.S. patient with the untreatable superbug infection, following a Pennsylvania patient first made public last month.
The mcr-1 gene gives bacteria resistance to colistin, a last-line-of-defense antibiotic used to combat a number of resistant microorganisms.
Going into 2017, the White House has requested $1.1 billion be allocated to efforts to combat antibiotic resistance in the U.S.
Cleanliness Is a Measurable Outcome
Workplace Safety and the Role of Access Control
Henry Ford Hospital Celebrates Construction Milestone for Expansion Project
How EVS Leaders Can Support Staff for Better Cleaning
Addressing Infection Prevention Staffing Gaps in Ambulatory and Procedural Care